ImCare Biotech is a biotechnology company founded in 2011 by Dr. Xuanyong Lu, formerly a professor at Drexel University’s Institute for Biotechnology and Virology.

The company’s primary products in development are innovative diagnostic biomarkers as well as developmental drugs for the treatment of liver diseases such as hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).

ImCare Biotech’s main R&D center is located in Doylestown, PA, USA and includes a modern fully-equipped laboratory focused on molecular biology and tissue cultures. The company has an operational presence in the US and Germany.